Summary sheet
Germitec is specialised in the High-Level Disinfection of probes using its proprietary Ultraviolet Light High-Level Disinfection (UV-C HLD) technology. Since its inception, it has been leading the way in developing sustainable and eco-friendly UV-C High-Level Disinfection technologies for reprocessing non-lumen medical devices.
The aim is to support the promoter's research and development (R&D) investments, Clinical and Regulatory spending as well as early market access expenses that are required to advance the development and market access of devices for the High-Level Disinfection of probes using Ultraviolet Light High-Level Disinfection (UV-C HLD) technology.
The project mainly concerns investments in R&D and market access. All R&D investments are expected to be carried out in existing facilities already authorised for the same purpose and would therefore not require an environmental impact assessment (EIA) under the Directive 2014/52/EU amending the EIA Directive 2011/92/EU. Full environmental details will be verified during the appraisal.
Germitec is a private company not operating in the utilities sector and not having the status of a contracting authority; thus, the project is not covered by the EU Directives on procurement. However, the promoter's procurement procedures are expected to be in line with EIB's guidelines for private sector projects. The EIB will verify details during the project due diligence.
Germitec is a French commercial stage innovative medical device company specialized in the High-Level Disinfection of probes usingUltraviolet Light High-Level Disinfection (UV-C HLD) technology.
Disclaimer
Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).
News & Stories
General enquiries and comments
The EIB is committed to open communication and encourages constructive stakeholder input regarding its activities.
Enquiries and comments concerning the EIB’s involvement in a project or the financing facilities, activities, organisation and objectives of the EIB, can be sent to the EIB Infodesk.
Alternatively, the EIB can be contacted through its external offices.
Queries regarding details of a specific project, in particular when it is under appraisal by the EIB, should preferably be addressed directly to project promoters.
Media enquiries
Media-related enquiries can be addressed to the EIB Press Office. Please also visit our Media information section.
Complaints mechanism
Any complaint regarding alleged maladministration can be lodged via the EIB Complaints Mechanism. The European Ombudsman acts as an independent external accountability mechanism of the EIB.
Zero tolerance against fraud and corruption
The EIB has a zero tolerance policy on fraud or corruption. To report allegations of fraud and corruption relating to EIB-financed projects, please contact the Fraud and Investigation division. All complaints will be treated as strictly confidential and handled in line with the EIB investigation procedures and the Anti-Fraud Policy.
Related publications